Sep 10, 2023, 00:15
Sarah Sammons: Expectation and knowledge is power. Surprise is anxiety provoking and perpetually shocking.
Sarah Sammons, Breast Medical Oncologist and Associate Director EMBRACE Metastatic Breast Cancer Program, stated the following on Twitter:
“It’s important to share with pts with HR+ MBC that after progression on CDK4/6 inhibitors, regimens usually work for shorter amounts of time. Changing therapy becomes more frequent.
Expectation and knowledge is power. Surprise is anxiety provoking and perpetually shocking.”
Source: Sarah Sammons / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19